论文部分内容阅读
目的探明恶性血液病住院费用结构，探讨合理调控策略。方法 单纯随机抽样调查，统计学采用ｔ检验，二元变量相关分析。结果 恶性血液病住院费用显著高于良性血液病（Ｐ＜０．０１）；住院费用与病种、分期不相关（ｐ＞０．０５）；与治疗效果（预后）呈负相关（ｒ＝－０.３６５，ｐ＜０．００１）；与药费呈正相关（ｒ＝０.９５１， ｐ＜ ０．００１）。结论控制住院费用增长的关键是控制药费，提高社会效益和经济效益的根本是提高医护服务质量。
Objective To explore the structure of hospitalization costs for hematological malignancies and to explore strategies for rational regulation. Methods Simple random sampling survey, statistical analysis using t test, binary variable correlation analysis. Results The hospitalization cost of hematologic malignancy was significantly higher than that of benign hematopathy (P<0.01); the hospitalization cost was not related to the disease type and stage (p>0.05); it was negatively correlated with the therapeutic effect (prognosis) (r=- 0.365, p<0.001); positively correlated with drug costs (r=0.951, p<0.001). Conclusion The key to controlling the growth of hospitalization costs is to control the cost of drugs, and to improve the social benefits and economic benefits is to improve the quality of health care services.